AAOpt 2023: Taking advantage of everything OCT has to offer
Optometry Times sat down with Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, to discuss his upcoming presentations at AAOpt.
AAOpt 2023: Contact Lens Institute report takeaways
Ariel Cerenzie, OD, FAAO, FSLS, shares highlights from the recently released Contact Lens Institute report on contact lens culture.
AAOpt 2023: Navigating the evolution of glaucoma and MIGS
Gleb Sukhovolskiy discusses his 2023 AAOpt presentation, "Optometrist’s Guide to MIGS and the Continuing Evolution of Glaucoma Treatment."
AAOpt 2023: Understanding nystagmus and providing better patient care
Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.
AAOpt 2023: Preventing dropout in glaucoma due to dry eye
At AAOpt, Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss the intersection of dry eye and glaucoma.
VEW: Creating a contact lens culture in your practice
The Contact Lens Institute and The Vision Council presented a sneak peek of its forthcoming report, “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success,” which will be published in mid-October 2023.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Exciting things in the pipeline for the American Academy of Orthokeratology and Myopia Control
AAOMC is focusing on new membership growth, diversity, and how they can continue to move the needle in myopia management.
CRU 2023: Learn to care for your patients' retinas with genetic testing
The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.
FDA approves XDEMVY, the first and only treatment for Demodex blepharitis
Dr Selina McGee, OD, FAAO, Dipl ABO, met with Optometry Times to discuss the recent FDA approval of XDEMVY, a treatment for Demodex blepharitis, from Tarsus Pharmaceuticals.
EyeCon 2023: Bringing collaborative OD and MD education to life
Hear from A. Paul Chous, OD, MA, FAAO, and what to look forward to during the 2023 EyeCon meeting December 1-2 in Sanibel Harbour, FL.
Meet the LEO founding board: Dr Diana Canto-Sims
Diana Canto-Sims, OD, sat down with Optometry Times®' assistant managing editor Emily Kaiser to talk about her role on the founding board of Latinos en Optometry (LEO).
CRU 2023: Experience Napa Valley as part of an intimate eye care symposium
Learn about the second annual CRU Eye Symposium, the intentions behind the meeting, and what to expect.